How to diagnose high-altitude polycythemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Diagnose High-Altitude Polycythemia

High-altitude polycythemia (HAPC) is diagnosed when hemoglobin is ≥190 g/L in females or ≥210 g/L in males in individuals living at high altitude (typically >4000 m), combined with clinical symptoms of chronic mountain sickness. 1, 2, 3

Diagnostic Criteria

Primary Hemoglobin Thresholds

  • Males: Hemoglobin ≥210 g/L 1, 2, 3
  • Females: Hemoglobin ≥190 g/L 1, 2, 3
  • These thresholds are specifically defined for high-altitude populations and differ from polycythemia vera criteria 1

Associated Clinical Features

  • Decreased arterial oxygen saturation despite elevated hemoglobin 4
  • Symptoms of chronic mountain sickness including headache, dizziness, and sleep disturbances 3
  • Residence at high altitude (typically >4000 m elevation) 2, 3

Critical Distinction: HAPC vs Polycythemia Vera

The most important diagnostic step is distinguishing HAPC from polycythemia vera (PV), as they require completely different therapeutic approaches. 1

Features Suggesting Polycythemia Vera Rather Than HAPC

  • Leukocytosis and thrombocytosis (PV typically shows elevated white blood cells and platelets, while HAPC may show thrombocytopenia) 1, 5
  • Hypochromic microcytic red blood cells with low mean corpuscular volume (MCV) and mean corpuscular hemoglobin concentration (MCHC) due to iron deficiency 1, 6
  • Low serum erythropoietin (EPO) level (<2 U/L strongly favors PV) 7, 8
  • JAK2 mutation positivity (present in >95% of PV cases) 7, 8

When to Test for Polycythemia Vera at High Altitude

Many patients with polycythemia at altitude are unnecessarily evaluated for PV if hemoglobin/hematocrit is the sole criterion. 1 Consider PV testing only when:

  • Leukocytosis and/or thrombocytosis are present alongside polycythemia 1
  • Microcytic hypochromic anemia pattern suggests iron deficiency (which is characteristic of PV, not typical HAPC) 1, 6
  • Unusual thrombosis occurs (such as Budd-Chiari syndrome) 7
  • Aquagenic pruritus or erythromelalgia are present 7

Diagnostic Algorithm for High-Altitude Polycythemia

Step 1: Confirm Elevated Hemoglobin

  • Verify hemoglobin ≥210 g/L (males) or ≥190 g/L (females) 1, 2, 3
  • Ensure adequate hydration to exclude relative polycythemia from dehydration 9
  • Repeat complete blood count if initial values are borderline 9

Step 2: Assess Complete Blood Count Pattern

  • If isolated erythrocytosis (normal white blood cells and platelets, normocytic red cells): likely HAPC 1
  • If pancytosis (elevated white blood cells, platelets, and red cells) with microcytosis: consider PV and proceed to Step 3 1

Step 3: Measure Serum Erythropoietin (Only if PV Suspected)

  • Low EPO (<2 U/L): strongly suggests PV, proceed to JAK2 testing 7, 8
  • Normal or elevated EPO: consistent with HAPC (appropriate physiologic response to hypoxia) 7, 4

Step 4: JAK2 Mutation Testing (Only if PV Strongly Suspected)

  • Positive JAK2V617F or exon 12 mutation confirms PV 8, 7
  • Negative result does not completely exclude PV but makes HAPC more likely in high-altitude context 8

Additional Laboratory Findings in HAPC

Characteristic Blood Changes

  • Significantly increased hematocrit values 2, 4
  • Increased reticulocyte count (reflecting enhanced bone marrow erythropoiesis) 4
  • Possible thrombocytopenia (unlike PV, which shows thrombocytosis) 5
  • Increased 2,3-bisphosphoglycerate (2,3-BPG) levels facilitating oxygen release 4

Erythrocyte Morphology and Function

  • Increased proportion of abnormal erythrocytes (vesicular erythrocytes and acanthocytes) 4
  • Increased erythrocyte osmotic fragility 4
  • Reduced erythrocyte apoptosis contributing to polycythemia 4

Common Diagnostic Pitfalls

Do Not Assume All High-Altitude Polycythemia is Secondary

  • While most polycythemia at altitude is physiologic adaptation (HAPC), approximately 16.7% of cases evaluated may actually be PV 1
  • The key is using the complete blood count pattern to guide selective testing rather than reflexively ordering JAK2 testing for all elevated hemoglobin at altitude 1

Do Not Overlook Iron Deficiency

  • Iron deficiency with microcytosis in the context of polycythemia strongly suggests PV rather than HAPC 1, 6
  • Low MCHC (<32%) indicates iron deficiency that can mask the true degree of erythrocytosis 6, 9

Do Not Rely on Red Cell Mass Measurement

  • Red cell mass measurement is costly and not routinely needed for HAPC diagnosis 8, 9
  • Normal red cell mass does not exclude polycythemia vera 8, 7

References

Guideline

Diagnostic Approach to Polycythemia Vera with Iron Deficiency

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnostic Approach for Polycythemia Vera

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Blood Tests for Monitoring Polycythemia Vera

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.